BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:Translational Neuroscience Drug Discovery Course
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_1119544_0
SUMMARY:Translational Neuroscience Drug Discovery Course
DESCRIPTION:<p>	<span><span style="color:black">This spring the TNC will be offering a short course on the basics of preclinical drug discovery for the neuroscience community. It is intended to give translational neuroscientists insight into the drug discovery process and an overview of the local pharmaceutical industry landscape. Lectures from local industry experts will be offered to cover different aspects of the drug discovery process. Lectures will be in CLS12 on each Wednesday from April 4 to May 9 at 4:00-5:00pm. Don’t miss this opportunity! Online </span></span><a data-url="https://www.eventbrite.com/e/drug-discovery-for-neuroscience-course-tickets-43752628289" href="https://www.eventbrite.com/e/drug-discovery-for-neuroscience-course-tickets-43752628289" target="_blank" title="TNC Course Registration Link">registration</a><span><span style="color:black"> now available. For questions, please contact </span></span><a href="mailto:///tnc@childrens.harvard.edu">tnc@childrens.harvard.edu</a><span><span style="color:black">. </span></span></p><p>	<strong><u><span><span style="color:black">Drug Discovery for Neuroscientists</span></span></u></strong></p><p>	<span><span style="color:black">Wednesdays 4-5pm, CLS 12</span></span></p><p>	<span><span style="color:black">April 4<sup>th</sup> – May 9<sup>th</sup>, 2018</span></span></p><p>	<em>(Please note the exception: Early Phase Clinical Trials with Keith Gottesdiener will be held on Tuesday, May 1, 2018)</em></p><p>	<u><span><span style="color:black">Agenda:</span></span></u></p><p>	<span><span style="color:black">4/4/18 <strong><span>Introduction to Drug Discovery</span></strong></span></span></p><p>	<span><span style="color:black">Meera Modi, <em>BCH</em></span></span></p><p>	<span><span style="color:black">4/11/18 <strong><span>Biology: Building a Preclinical Rationale</span></strong></span></span></p><p>	<span><span style="color:black">Robin Kleiman, <em>Biogen</em></span></span></p><p>	<span><span style="color:black">4/18/18 <strong><span>Animal Models in Drug Discovery</span></strong></span></span></p><p>	<span><span style="color:black">Michelle Sidor, <em>Novartis Institute for BioMedical Research</em></span></span></p><p>	<span><span style="color:black">4/25/18<strong> </strong><strong><span> A Case Study in PK/PD</span></strong></span></span></p><p>	<span><span style="color:black">Stephen Wood, <em>Amgen </em></span></span></p><p>	<span><span style="color:black">5/1/18 <strong><span>Early Phase Clinical Trials</span></strong></span></span></p><p>	<span><span style="color:black">Keith Gottesdiener, <em>Rhythm Pharmaceuticals</em></span></span></p><p>	<span><span style="color:black">5/9/18 <strong><span>The Interface Between Industry and Academia</span></strong></span></span></p><p>	<span><span style="color:black">Nick Brandon, <em>AstraZeneca</em></span></span></p>
LOCATION:Boston Children's Hospital, CLS12
STATUS:CONFIRMED
DTSTART:20180404T200000Z
DTEND:20180404T210000Z
END:VEVENT
END:VCALENDAR